Nan Fung Group Holdings as of June 30, 2024
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 44 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Illumina (ILMN) | 13.3 | $12M | 119k | 104.38 | |
| Harmony Biosciences Hldgs In (HRMY) | 11.9 | $11M | 369k | 30.17 | |
| Merus N V (MRUS) | 7.6 | $7.1M | 120k | 59.17 | |
| Geron Corporation (GERN) | 6.2 | $5.8M | 1.4M | 4.24 | |
| Oculis Holding Ordinary Shares (OCS) | 5.6 | $5.2M | 436k | 11.95 | |
| Incyte Corporation (INCY) | 4.8 | $4.5M | 74k | 60.62 | |
| Exscientia Ads (EXAI) | 4.7 | $4.4M | 860k | 5.10 | |
| Xenon Pharmaceuticals (XENE) | 4.4 | $4.2M | 107k | 38.99 | |
| Longboard Pharmaceuticals In (LBPH) | 4.2 | $3.9M | 145k | 27.03 | |
| Mirum Pharmaceuticals (MIRM) | 3.9 | $3.6M | 106k | 34.19 | |
| D Fluidigm Corp Del (LAB) | 3.6 | $3.3M | 1.9M | 1.77 | |
| Beigene Sponsored Adr (BGNE) | 3.5 | $3.3M | 23k | 142.67 | |
| Kalvista Pharmaceuticals (KALV) | 2.8 | $2.6M | 219k | 11.78 | |
| Rhythm Pharmaceuticals (RYTM) | 2.2 | $2.0M | 49k | 41.06 | |
| Tourmaline Bio (TRML) | 2.0 | $1.9M | 147k | 12.86 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 2.0 | $1.9M | 494k | 3.80 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.0 | $1.9M | 14k | 136.38 | |
| Replimune Group (REPL) | 2.0 | $1.8M | 205k | 9.00 | |
| ACADIA Pharmaceuticals (ACAD) | 1.8 | $1.7M | 103k | 16.25 | |
| Madrigal Pharmaceuticals (MDGL) | 1.7 | $1.6M | 5.7k | 280.16 | |
| Exelixis (EXEL) | 1.5 | $1.4M | 64k | 22.47 | |
| Zai Lab Adr (ZLAB) | 1.0 | $953k | 55k | 17.33 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $890k | 11k | 82.33 | |
| Bolt Biotherapeutics (BOLT) | 0.9 | $875k | 1.2M | 0.75 | |
| Entrada Therapeutics (TRDA) | 0.7 | $699k | 49k | 14.25 | |
| Athira Pharma (ATHA) | 0.5 | $477k | 180k | 2.65 | |
| Pacific Biosciences of California (PACB) | 0.4 | $376k | 275k | 1.37 | |
| Cabaletta Bio (CABA) | 0.4 | $353k | 47k | 7.48 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.4 | $350k | 17k | 20.24 | |
| Roivant Sciences SHS (ROIV) | 0.4 | $343k | 33k | 10.57 | |
| Kymera Therapeutics (KYMR) | 0.3 | $325k | 11k | 29.85 | |
| Grail (GRAL) | 0.3 | $305k | 20k | 15.37 | |
| Revolution Medicines (RVMD) | 0.3 | $283k | 7.3k | 38.81 | |
| Springworks Therapeutics (SWTX) | 0.3 | $281k | 7.5k | 37.67 | |
| Alx Oncology Hldgs (ALXO) | 0.3 | $253k | 42k | 6.03 | |
| Immunocore Hldgs Ads (IMCR) | 0.2 | $229k | 6.8k | 33.89 | |
| Affimed N V Ordinary Shs New (AFMD) | 0.2 | $203k | 37k | 5.45 | |
| Immatics SHS (IMTX) | 0.2 | $182k | 16k | 11.62 | |
| Biomea Fusion (BMEA) | 0.2 | $180k | 40k | 4.50 | |
| Abcellera Biologics (ABCL) | 0.2 | $151k | 51k | 2.96 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.2 | $149k | 186k | 0.80 | |
| Aerovate Therapeutics (AVTE) | 0.1 | $80k | 48k | 1.66 | |
| Kodiak Sciences (KOD) | 0.1 | $75k | 32k | 2.35 | |
| Fibrogen (FGEN) | 0.1 | $55k | 62k | 0.89 |
